Innovent Biologics IncEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 89.9 HKD | 109,1 HKD | 69,55 HKD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - HKD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.740.920.818 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Innovent Biologics Inc
Mitarbeiter 7.502
Handelsplatz HK
Ticker Symbol 1801
IPO Datum -
Adresse 168 Dongping Street, Suzhou, China, 215123
Webseite https://www.innoventbio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. De-Chao Yu Ph.D. | Co-Founder, Chairman & CEO |
| 2 | Mr. Hao Xi Ede | Executive Director & Fund Managing Partner |
| 3 | Ms. Qian Zhang | Chief Commercial Officer, General Manager & Executive Director |
| 4 | Ms. Fei You CPA | Chief Financial Officer |
| 5 | Dr. Kaisong Zhou Ph.D. | Chief Operating Officer |
| 6 | Ms. Zhengwei Song C.F.A. | Director of IR & Financial Strategy |
| 7 | Ms. Cong Ding J.D. | General Counsel |
| 8 | Mr. Blake Salisbury | Senior Vice President |
| 9 | Dr. Hui Zhou Ph.D. | Chief R&D Officer for Oncology |
| 10 | Dr. Samuel Suhua Zhang M.B.A., Ph.D. | Global Chief Business Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.